A Patient-Spouse Intervention for Self-Managing High Cholesterol

Not Applicable

Completed

• Conditions: Hypercholesterolemia
• Interventions: Behavioral: spouse-assisted intervention

• Registration Number: NCT00321789
• Lead Sponsor: US Department of Veterans Affairs

Brief Summary

We examined the effect of a patient-spouse intervention to lower LDL-C by increasing patient treatment adherence. A randomized controlled trial compared a one-year, telephone-based patient-spouse intervention to usual care. The primary outcome was LDL-C measured three times (baseline, 6 months, 11 months); secondary outcomes were adherence to medication, diet, and exercise, also assessed at baseline, 6 months, and 11 months.

Detailed Description

Background: Background/Rationale: Coronary heart disease (CHD) is the leading cause of death in the United States, resulting in more than 500,000 heart attacks and another 500,00 deaths per year. More than 80% of veterans have \> 2 risk factors for CHD, underscoring the need for intervention. One major modifiable risk factor for CHD is elevated low-density lipoprotein cholesterol (LDL-C). Despite the proven success of diet, exercise, and medication, LDL-C frequently is not at the optimum level, due in part to patient nonadherence. Therefore, interventions are needed to increase adherence, thereby lowering LDL-C.

Objectives: Objectives: We examined the effect of a patient-spouse intervention to lower LDL-C by increasing patient treatment adherence. The primary hypothesis was that patients enrolled in a telephone-based, spouse-assisted intervention will experience a clinically meaningful 7% reduction in LDL-C. The secondary hypotheses were that patients who receive the intervention would show a significant increase in adherence to medication, diet, and exercise.

Methods: In a 3-year study, a randomized controlled trial compared a 10-month, telephone-based, spouse-assisted intervention to usual care. Married patients with above-goal LDL-C and their spouses were consented, completed a baseline assessment, and then were randomly assigned to the intervention or usual care arm. Month 1 involved an educational call delivered to patients and spouses. Months 2-10 (except month 6) involved monthly goal setting calls delivered to patients and calls focused on increasing social support to spouses. The patient phone call will always preceded the spouse phone call. At 6 and 11 months, LDL-C and adherence were re-assessed. The primary outcome was LDL-C measured three times (baseline, 6 months, 11 months); secondary outcomes were adherence to medication, diet, and exercise, also assessed at baseline, 6 months, and 11 months. Descriptive statistics were computed for all study variables within each study arm. Mixed effects models were used to evaluate the intervention's effect on the primary and secondary outcomes at 11 months. We also calculated intervention cost.

Status: Enrollment began in Fall, 2007 and was completed in July of 2009.

Impact: Elevated LDL-C is a major risk factor for CHD, stroke, and peripheral vascular disease, all of which are common among veterans. The expected increase in prevalence of CHD over the next several decades will result in an increased burden for both veterans and the VA health care system. Despite the known risk of hypercholesterolemia, many veterans have suboptimal LDL-C levels. As the latest evidence and recommendations suggest that these goals should be even lower, interventions to assist patients to lower LDL-C increasingly will be needed. The VA considers the reduction of LDL-C an important goal, as indicated by the major effort of the Ischemic Heart Disease Quality Enhancement Research Initiatives (QUERI). This study is important because (1) it addresses a highly prevalent risk factor for CHD among veterans; (2) it proposes a potentially low-cost method for improving LDL-C levels, which in turn could reduce VA healthcare costs; (3) the intervention is practical and could be disseminated easily in the VA healthcare system if proven effective; and (4) this intervention provides a model for self-management of other chronic diseases, such as diabetes and hypertension.

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study First Submitted: 2006-05-03
• Study First Submitted QC: 2006-05-03
• Study First Posted: 2006-05-04
• Study Start: 2007-09
• Primary Completion: 2010-07
• Study Completion: 2010-08
• Status Verified: 2014-08
• Results First Submitted: 2014-09-02
• Results First Submitted QC: 2014-09-25
• Results First Posted: 2014-09-26
• Last Update Submitted: 2015-04-06
• Last Update Posted: 2015-04-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 255

Inclusion Criteria

• veteran
• elevated baseline low-density lipoprotein cholesterol level
• married

Read More

Exclusion Criteria

• no telephone number;
• spouse unwilling to participate;
• patient or spouse cognitively impaired, unable to communicate via telephone, living in nursing home or receiving home health care, or refuses to provide informed consent;
• hospitalized past 3 months;
• survival prognosis less than 1 year;
• active psychosis or dementia; no primary care physician at VA;
• no medical visit to VA in past year;
• enrolled in another study focusing on lifestyle changes

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Spouse-assisted intervention	spouse-assisted intervention	Couples assigned to this arm received nine monthly phone calls from a nurse. The patient created goals and action plans related to diet, exercise, patient-provider communication, or medication adherence. The spouse developed a plan to support patient goal achievement.

Primary Outcome Measures

Name	Time	Method
Low-density Lipoprotein Cholesterol	11-month follow-up	assessed with non-fasting blood test

Secondary Outcome Measures

Name	Time	Method
Total Fat (Grams/Day)	11-month follow-up	Self-reported, assessed via Block Brief Food Frequency Questionnaire (FFQ).
Duration of Moderate Intensity Physical Activity	11-month follow-up	Self-reported via Community Health Activities Model Program for Seniors questionnaire.
Caloric Intake	11-month follow-up	Self-reported, assessed via Block Brief Food Frequency Questionnaire (FFQ).
Saturated Fat (Grams/Day)	11-month follow-up	Self-reported, assessed via Block Brief Food Frequency Questionnaire (FFQ).
Cholesterol Intake	11-month follow-up	Self-reported, assessed via Block Brief Food Frequency Questionnaire (FFQ).
Fiber Intake	11-month follow-up	Self-reported, assessed via Block Brief Food Frequency Questionnaire.
Frequency of Moderate Intensity Physical Activity	11-month follow-up	Self-reported via Community Health Activities Model Program for Seniors questionnaire.
Total Fat (%)	11-month follow-up	Self-reported, assessed via Block Brief Food Frequency Questionnaire (FFQ).
Saturated Fat (%)	11-month follow-up	Self-reported, assessed via Block Brief Food Frequency Questionnaire (FFQ).
Number of Participants With Goal LDL-C	11-month follow-up	Assessed via non-fasting blood test. Goal is determined by 2003 National Cholesterol Education Program guidelines. Goal could be 160mg/dL for low risk (no coronary heart disease (CHD), 0-1 risk factor); 130 mg/dL for medium risk (no CHD, at least 2 risk factors); or 100 mg/dL for high risk (CHD and risk equivalents including diabetes, atherosclerotic disease, and multiple risk factors that confer a 10-year risk for CHD \>20% per Framingham score).
Number of Participants Prescribed Cholesterol Medication	11-month follow-up	This was assessed via electronic medical record abstraction. Results could not be modeled statistically due to missing data/small cell sizes (i.e., not all participants had a prescription for medication because this was not an inclusion criterion).

Trial Locations

Locations (1)

Durham VA Medical Center, Durham, NC; 🇺🇸 Durham, North Carolina, United States